Efficacy and safety of ribavirin+sofosbuvir in patients with hepatitis C virus related cirrhosis: Retrospective study

Trial Profile

Efficacy and safety of ribavirin+sofosbuvir in patients with hepatitis C virus related cirrhosis: Retrospective study

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Dec 2015

At a glance

  • Drugs Ribavirin (Primary) ; Sofosbuvir (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions
  • Most Recent Events

    • 22 Dec 2015 New trial record
    • 30 Nov 2015 Results published in the Journal of Hepatology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top